Taysha Gene Therapies Cash Flow Statement (2019-2026) | TSHA

Cash Flow Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-51.22M-24.55M-50.63M-34.12M-26.54M-56.01M-28.18M-55.53M-26.04M-15.66M-36.93M-29.45M-52.88M-23.43M-28.59M-51.17M-61.99M-25.44M-98.11M-159.39M
Depreciation and Depletion (Quarter)
0.20M0.19M0.26M0.30M0.30M0.36M0.33M0.40M0.30M0.40M0.30M0.30M0.30M0.30M0.30M0.30M0.20M0.30M0.30M0.40M
Share-based Compensation (Quarter)
5.09M4.96M5.33M4.14M4.47M4.10M1.68M2.22M2.04M1.97M3.20M3.33M3.36M3.22M3.29M3.19M3.29M3.53M28.10M5.81M
Gains from Investment Securities (Quarter)
-65.96M0.34M-0.20M-0.07M-0.08M-0.10M0.27M0.29M0.74M
Asset Writedowns and Impairment (Quarter)
0.62M0.45M4.84M
Cash from Operations (Quarter)
-31.93M-40.26M-40.94M-33.35M-28.81M14.71M-20.18M-18.77M-17.95M-16.12M-19.80M-21.50M-21.61M-18.31M-22.02M-20.18M-24.17M-26.72M-40.88M-40.42M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.31M0.34M0.39M0.28M0.30M0.30M0.30M0.27M0.33M0.29M0.30M0.30M0.34M0.31M0.31M0.40M0.28M0.27M
Depreciation & Amortization (CF) (Quarter)
0.20M0.19M0.26M0.30M0.30M0.36M0.33M0.40M0.30M0.40M0.30M0.30M0.30M0.30M0.30M0.30M0.20M0.30M0.30M0.40M
Change in Working Capital
Change in Account Payables (Quarter)
16.01M-16.01M2.54M3.67M-9.43M-4.59M0.36M1.76M-3.19M-1.23M3.98M-1.61M-3.78M-1.50M0.92M3.00M-1.95M-2.13M1.29M4.56M
Change in Accured Expenses (Quarter)
-2.87M5.36M-0.78M-7.68M-0.12M-0.75M-0.25M-1.07M-2.94M-2.02M0.42M-2.38M0.43M0.11M-2.12M0.73M5.01M2.67M-5.15M0.86M
Other Working Capital Changes (Quarter)
-4.71M-2.40M-4.75M-3.60M-3.41M-1.11M-1.79M-2.02M-2.30M-1.99M-5.49M
Investing Activities
Capital Expenditures (Quarter)
3.50M8.27M0.02M0.09M-0.07M20.58M3.90M-0.05M-3.43M3.45M0.14M0.30M-0.07M-0.00M0.02M0.39M-0.39M0.71M0.02M0.35M
Cash from Investing Activities (Quarter)
-4.00M-8.52M-11.43M-8.11M-3.02M-2.37M-3.90M0.05M-3.49M-0.01M-0.14M-0.20M-0.04M0.01M-0.37M0.06M-0.05M-0.25M-3.02M0.00M
Financing Activities
Other financing activities (Quarter)
-0.23M0.55M-0.07M-1.29M0.05M-0.30M0.32M0.03M-0.24M0.30M0.07M-0.04M-0.28M1.88M0.02M0.44M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
10.00M
Change in Capital Stock
Shares Issued (Quarter)
0.08M1.65M4.72M5.15M4.55M1.07M5.23M2.41M2.57M7.16M4.53M3.40M2.51M3.70M4.71M3.46M0.45M24.57M4.46M3.48M
Net Equity Issued and Repurchased (Quarter)
0.04M16.08M
Misc.
Cash from Financing Activities (Quarter)
9.11M-0.11M11.07M-0.10M41.23M-0.37M0.38M140.63M-4.25M-0.02M70.47M6.59M-0.36M-0.05M216.29M8.80M49.56M0.71M216.66M
Change in Cash (Quarter)
-5.96M-39.67M-52.47M-30.39M-31.93M53.57M-24.45M-18.34M119.19M-20.38M-19.96M48.76M-15.05M-18.65M-22.44M196.17M-15.42M22.59M-43.19M176.23M
Free Cash Flow (Quarter)
-35.44M-48.53M-40.96M-33.44M-28.74M-5.87M-24.09M-18.72M-14.52M-19.56M-19.94M-21.81M-21.55M-18.31M-22.04M-20.57M-23.78M-27.43M-40.90M-40.78M
Net Cash Flow (Quarter)
-35.94M-39.67M-52.47M-30.39M-31.93M53.57M-24.45M-18.34M119.19M-20.38M-19.96M48.76M-15.05M-18.65M-22.44M196.17M-15.42M22.59M-43.19M176.23M